Journal Article

Sirolimus interacts with pathways essential for podocyte integrity

Emmanuel Letavernier, Patrick Bruneval, Sophie Vandermeersch, Joelle Perez, Chantal Mandet, Marie-France Belair, Jean-philippe Haymann, Christophe Legendre and Laurent Baud

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 24, issue 2, pages 630-638
Published in print February 2009 | ISSN: 0931-0509
Published online October 2008 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/gfn574
Sirolimus interacts with pathways essential for podocyte integrity

Show Summary Details

Preview

Background. The specific mTor inhibitor sirolimus has been implicated in the pathogenesis of renal glomerular lesions and nephrotic syndrome appearance after transplantation. Podocyte injury and focal segmental glomerulosclerosis have been related to sirolimus therapy in some patients but the pathways underlying these lesions remain hypothetical.

Methods. To go further in the comprehension of these mechanisms, primary cultures of human podocytes were exposed to therapeutic-range concentrations of sirolimus.

Results. Cell viability was not affected after 2 days’ exposure to the drug but changes in cell phenotype and cytoskeleton reorganization were observed. We also evidenced that vascular endothelial growth factor (VEGF) synthesis and Akt phosphorylation were decreased by sirolimus addition. We did not observe any loss of podocyte differentiation markers with the notable exception of WT1, a transcription factor essential for maintaining podocyte integrity. WT1 gene and protein expression in podocytes were decreased in a dose-dependent manner after incubation with sirolimus.

Conclusion. Taken together, these data suggest that sirolimus could impair pathways essential for podocyte integrity and therefore predisposes to glomerular injury.

Keywords: podocyte; sirolimus; toxicity; VEGF; WT1

Journal Article.  4484 words.  Illustrated.

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.